Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-33.70	34.65	52.27
Graham Fair Price	10.70	13487.28	12184.08
PEG	-98.30	0.35	-20.52
Price/Book	7.16	0.94	0.87
Price/Cash Flow	-23.39	64.79	84.58
Prices/Earnings	-17.16	9.02	10.89
Price/Sales	-7.88	9.09	9.87
Price/FCF	-23.39	64.79	84.58
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	17.48	0.28	0.24
Operating Margin	73.21	0.21	0.12
ROA	23.35	0.02	0.02
ROE	0.02	0.03	29.36
ROIC	< 0.005	0.02	110.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.04	-46.36
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.58	0.96	66.34
EPS QOQ	< 0.005	0.26	4781.57
FCF QOQ	-0.81	0.36	-55.64
Revenue QOQ	-0.13	0.13	1.72
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.01	1.48	-26.09
Days Sales Outstanding (DSO)	9.11	8.69	-4.56
Inventory Turnover	44.86	60.69	35.30
Debt/Capitalization	< 0.005	< 0.005	7.92
Quick Ratio	1.97	1.56	-20.83
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18141.07	17656.01	-2.67
Cash	6652.10	6674.92	0.34
Capex	-183.92	-94.92	48.39
Free Cash Flow	187.28	254.96	36.14
Revenue	1604.83	1816.98	13.22
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.98	1.57	-20.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.77	-0.40	77.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating